Simplex Trading
EIGR

Simplex Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Simplex Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-437
Closed -$2K – 10234
2023
Q4 		$2K Buy
437
+31
+8% +$273 ﹤0.01% 8401
2023
Q3 		$3K Buy
406
+350
+625% +$7.04K ﹤0.01% 8006
2023
Q2 		$1K Buy
+56
New +$1.73K ﹤0.01% 8782
2023
Q1 		– Sell
-224
Closed -$10.4K – 10449
2022
Q4 		$7K Sell
224
-191
-46% -$22.9K ﹤0.01% 7885
2022
Q3 		$93K Buy
415
+297
+252% +$73K ﹤0.01% 5634
2022
Q2 		$22K Sell
118
-2,020
-94% -$407K ﹤0.01% 7512
2022
Q1 		$532K Buy
2,138
+1,808
+548% +$286K ﹤0.01% 3768
2021
Q4 		$51K Buy
+330
New +$63.8K ﹤0.01% 7245
2020
Q4 		– Sell
-177
Closed -$50.8K – 9266
2020
Q3 		$43K Buy
+177
New +$55.1K ﹤0.01% 5759
2016
Q1 		– Sell
-32
Closed -$21K – 6413
2015
Q4 		$21K Sell
32
-15
-32% -$8.49K ﹤0.01% 2657
2015
Q3 		$22K Sell
47
-26
-36% -$13.8K ﹤0.01% 2700
2015
Q2 		$41K Buy
73
+45
+161% +$125K ﹤0.01% 1854
2015
Q1 		$237K Buy
+28
New +$245K 0.03% 648

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Simplex Trading's EIGR Position: Q1 2024 in Review

Simplex Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.

Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Simplex Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 437 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $2K.
  • Simplex Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
  • Simplex Trading's Eiger BioPharmaceuticals, Inc. position peaked at $532K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.